Project number: 2002-651
Project Status:
Completed
Budget expenditure: $29,550.00
Principal Investigator: Paul Hardy-Smith
Organisation: Paul Hardy-Smith
Project start/end date: 13 Dec 2002 - 24 Aug 2004
Contact:
FRDC

Need

Whirling Disease is a chronic, debilitating wasting disease caused by Myxobolus cerebralis, a protozoan parasite. While the intermediate host of the parasite, a tubifex worm, is present in Australia, the parasite has never been detected in this country. It is however present in New Zealand where the bulk of salmonid imports into this country currently originate from. It is difficult to detect in imported fish. Infective spores can survive for considerable periods in fresh and frozen fillets.
Overseas it is a disease of salmonids; non salmonids have also been reported to be hosts.
There is a significant population of salmonids in Australia that would be susceptible to this disease were an outbreak to occur. These populations are valuable both commercially and recreationally.
It is extremely important to have in place options for dealing with an outbreak of the disease to minimize the impact of such an outbreak should it occur. It is also highly beneficial that such options have been considered and agreed to by relevant stakeholders before the emergency occurs. Such options would acknowledge this disease may be insidious in its onset so may go undetected for a long time. Spores can also survive the passage through the gut of birds.
While the Federal Government encourages a detection and eradication culture based on constant vigilance and a readiness to tackle any emergency, there are currently no accepted national guidelines for dealing with an outbreak of an exotic parasitic disease in finfish in Australia.
Hence there is a need to have a Disease Strategy Manual for Whirling Disease that describes details about the disease, response options and the preferred, nationally agreed-upon approach to its control. This is supported by the FRDC’s Subprogram’s Steering Committee who, through consultation with stakeholders from industry and governments have determined as a priority the need for this Manual.

Objectives

1. To develop a consensus between government and industry on a preferred control policy for whirling disease should an outbreak of this disease occur in Australia.
2. Preparation of final version of Whirling Disease - Disease Strategy Manual for submission to Aquaplan Business Group/Sceintific Advisory Committee which incorporates the preferred control policy. This will manual will enhance the capability of both terrestrial and aquatic animal health professionals to identify and efficently manage an emergency response in the event of a suspect or confrimed incursion of whirling disease in Australia.

Final report

ISBN: 0-9756047-0-8
Author: Paul Hardy-Smith
Final Report • 2004-06-24 • 2.04 MB
2002-651-DLD.pdf

Summary

Whirling disease is the disease of freshwater salmonid fish caused by the myxozoan parasite Myxobolus cerebralis. The parasite has never been detected in Australia, but is present in New Zealand and areas of North America, Europe, Africa and Asia. Whirling disease is a reportable disease in Australia.

In the May 2000 Budget, the Federal Government announced its Building a National Approach to Animal and Plant Health program. This initiative seeks to maintain Australia’s status as a sought after supplier of high quality, ‘clean, green’ agricultural produce. Within this initiative, funds were made available to Agriculture, Fisheries and Forestry – Australia (AFFA) as administered funds for the Program Emergency Management Planning for aquatic animal diseases. As per an Agreement between AFFA and the Fisheries Research and Development Corporation (FRDC), these monies are administered by the FRDC on AFFA’s behalf. The FRDC’s vehicle for delivery is the FRDC Aquatic Animal Health Subprogram. 

Related research

Industry
Industry
Industry
PROJECT NUMBER • 2022-135
PROJECT STATUS:
CURRENT

Minor use permit for Chloramine-T in marine and freshwater finfish

1. Obtain data to satisfy identified gaps, and collate available data, to satisfy specified requirements of a minor use permit application for the use of Chloramine-T (N-chloro-4-methylbenzenesulfonamide sodium salt) to treat bacterial or parasite infections in marine and freshwater finfish.
ORGANISATION:
University of Adelaide